SCHEMBL2972056

SCHEMBL2972056

CCCCc1ccc(-c2cc3c(cc2Br)CC(C)=C3)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 3/20 0.38
PSMB5 P28074 1/20 0.36
SKP2 Q13309 1/20 0.36
RARB P10826 3/20 0.36
SMN1; SMN2 Q16637 2/20 0.35
NPC1 O15118 1/20 0.35
NFKB1 P19838 1/20 0.35
MAPK1 P28482 1/20 0.35
RAB9A P51151 1/20 0.35
NFKB2 Q00653 1/20 0.35
RELA Q04206 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
NISCH Q9Y2I1 1/20 0.35
CA2 P00918 1/20 0.33
CTSV O60911 1/20 0.33
CTSL P07711 1/20 0.33
MPL P40238 2/20 0.33
EDNRB P24530 1/20 0.33
EDNRA P25101 1/20 0.33
BRS3 P32247 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2971431 0.95 HSD11B1 (0.38) HSD11B1PSMB5SKP2RARBSMN1; SMN2
SCHEMBL2962116 0.77 HSD11B1 (0.38) HSD11B1PSMB5SKP2RARBSMN1; SMN2
SCHEMBL2956690 0.77 NPC1 (0.37) HSD11B1PSMB5SKP2RARBSMN1; SMN2
SCHEMBL2961870 0.75 RARB (0.38) HSD11B1SKP2RARBSMN1; SMN2NPC1
SCHEMBL2975449 0.75 HSD11B1 (0.39) HSD11B1SKP2RARBSMN1; SMN2NPC1
SCHEMBL2967739 0.75 NISCH (0.38) HSD11B1PSMB5SKP2RARBSMN1; SMN2
SCHEMBL2959222 0.75 SKP2 (0.37) HSD11B1PSMB5SKP2RARBSMN1; SMN2
SCHEMBL2973789 0.75 HSD11B1 (0.39) HSD11B1PSMB5SKP2RARBSMN1; SMN2
SCHEMBL2962950 0.75 NPC1 (0.33) SMN1; SMN2NPC1NFKB1MAPK1RAB9A
SCHEMBL2961312 0.73 ALDH1A1 (0.38) MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7763562-B2 Heteroatom bridged metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2010-07-27 US disclosed
US-20070135597-A1 Heteroatom bridged metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. 2007-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070135597-A1 Heteroatom bridged metallocene compounds for olefin polymerization AP2M1, AP1M1, PYM1 HSD11B1 4377/4885PSMB5 1605/4885SKP2 2873/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.